Market revenue in 2023 | USD 325.6 million |
Market revenue in 2030 | USD 1,105.1 million |
Growth rate | 19.1% (CAGR from 2023 to 2030) |
Largest segment | Infectious diseases |
Fastest growing segment | Infectious Diseases |
Historical data | 2021 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Infectious Diseases |
Key market players worldwide | Moderna Inc, BioNTech SE ADR, CureVac NV Ordinary Shares, Arcturus Therapeutics Holdings Inc, Sanofi SA, GSK PLC, Pfizer Inc, AstraZeneca PLC, Argos Therapeutics, ETHRIS |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mrna therapeutics market will help companies and investors design strategic landscapes.
Infectious diseases was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the South Korea mrna therapeutics market based on infectious diseases covering the revenue growth of each sub-segment from 2021 to 2030.
The South Korea mRNA therapeutics market is anticipated to grow owing to increasing healthcare expenditure, favorable government initiatives, and growing demand for the mRNA vaccine for influenza and COVID-19.
Moreover, several vaccine manufacturing expansions by market players are expected to fuel the country’s market. For instance, in August 2022, Moderna, Inc. received marketing approval for Spikevax, an mRNA COVID-19 vaccine manufactured by Samsung Biologics locally in South Korea, as an end-to-end contract development & manufacturing service.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea mrna therapeutics market , including forecasts for subscribers. This country databook contains high-level insights into South Korea mrna therapeutics market from 2021 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account